While India is often seen as a backend operations haven for many sectors, for Mitra Biotech, it is the reverse. Although the company's founders are based in the United States it has located its research and development centre in Bengaluru.
The startup's patented technology platform, Canscript, helps hospitals and doctors figure the right combination and sequence of drugs to be administered to cancer patients.
"It is really exciting that ET has recognised our work," said Mallik Sundaram, chief executive of Mitra Biotech, on winning the ET Startup Award in the 'Top Innovator' category for 2016. "It acts as a recognition not just for the founders but for the company as a whole. Even broader than that, it could act as a motivation for other people."............Read more
Source: The Economic Times